Patrick R. Analyst PerformanceAnalyst at HC WainwrightPatrick R. is a stock analyst at HC Wainwright focused in the medical sector, covering 25 publicly traded companies. Over the past year, Patrick R. has issued 78 stock ratings, including and buy recommendations. While full access to Patrick R.'s proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick R.'s coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings78 Last 0 YearsBuy Recommendations100.00% 78 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution78RatingsDistribution of strong buy, buy, hold, and sell ratings by Patrick R..RatingPercentageCount Strong Buy0.0%0 ratings Buy100.0%78 ratings Hold0.0%0 ratings Sell0.0%0 ratingsthe majority (100.0%) have been Buy recommendations.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ96.0% of companies on NASDAQ24 companiesNYSE4.0% of companies on NYSE1 companyPatrick R., an analyst at HC Wainwright, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical24 companies96.0%Manufacturing1 company4.0%Patrick R. of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE16 companies64.0%MED - DRUGS4 companies16.0%MEDICAL SERVICES1 company4.0%MED - GENERIC DRG1 company4.0%MED - OUTP/HM CRE1 company4.0%BIOTECHNOLOGY1 company4.0%Miscellaneous1 company4.0% Patrick R.'s Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGHRSGH Research5/19/2026Lower Price Target$21.68$65.00Buy$0.0000.00% ROIALTAltimmune5/18/2026Reiterated Rating$2.79$20.00Buy$0.0000.00% ROIANROAlto Neuroscience5/11/2026Reiterated Rating$25.45$50.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals5/5/2026Reiterated Rating$297.92$510.00Buy$0.0000.00% ROIASMBAssembly Biosciences5/4/2026Reiterated Rating$27.37$50.00Buy$0.0000.00% ROICMPSCompass Pathways4/28/2026Reiterated Rating$8.89$70.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals4/27/2026Reiterated Rating$2.94$45.00Buy$0.0000.00% ROIIMCRImmunocore4/20/2026Reiterated Rating$31.41$100.00Buy$0.0000.00% ROIIMCRImmunocore4/14/2026Reiterated Rating$31.62$100.00Buy$0.0000.00% ROIANROAlto Neuroscience4/2/2026Reiterated Rating$21.69$50.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ASMBAssembly Biosciences3/26/2026Reiterated Rating$28.67$50.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals3/25/2026Reiterated Rating$325.35$510.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals3/25/2026Reiterated Rating$60.92$100.00Buy$0.0000.00% ROIATAIAtai Beckley3/17/2026Reiterated Rating$3.68$25.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics3/17/2026Reiterated Rating$3.96$25.00Buy$0.0000.00% ROIALTAltimmune3/16/2026Boost Price Target$3.60$25.00Buy$0.0000.00% ROISLNSilence Therapeutics3/13/2026Reiterated Rating$6.97$75.00Buy$0.0000.00% ROIALGSAligos Therapeutics3/11/2026Reiterated Rating$7.41$50.00Buy$0.0000.00% ROIQUREuniQure3/10/2026Reiterated Rating$17.99$70.00Buy$0.0000.00% ROIGOSSGossamer Bio3/6/2026Lower Price Target$0.52$5.00Buy$0.0000.00% ROIVIRVir Biotechnology3/4/2026Boost Price Target$8.91$20.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences3/4/2026Boost Price Target$80.17$145.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals3/3/2026Boost Price Target$1.84$45.00Buy$0.0000.00% ROIPHVSPharvaris3/3/2026Reiterated Rating$27.37$60.00Buy$0.0000.00% ROIGHRSGH Research3/2/2026Boost Price Target$14.85$70.00Buy$0.0000.00% ROIATAIAtai Beckley3/2/2026Boost Price Target$3.63$25.00Buy$0.0000.00% ROICMPSCompass Pathways3/2/2026Boost Price Target$6.90$70.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics3/2/2026Boost Price Target$17.45$70.00Buy$0.0000.00% ROIHELPCybin3/2/2026Boost Price Target$7.35$95.00Buy$0.0000.00% ROIHRMYHarmony Biosciences2/25/2026Reiterated Rating$28.34$55.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/18/2026Reiterated Rating$332.30$510.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals2/10/2026Reiterated Rating$62.56$100.00Buy$0.0000.00% ROIQUREuniQure2/10/2026Reiterated Rating$26.05$70.00Buy$0.0000.00% ROISGMOSangamo Therapeutics2/10/2026Reiterated Rating$0.40$10.00Buy$0.0000.00% ROIIMCRImmunocore2/4/2026Reiterated Rating$32.07$100.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/30/2026Lower Price Target$346.79$510.00Buy$0.0000.00% ROIGOSSGossamer Bio1/22/2026Reiterated Rating$2.74$10.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals1/21/2026Reiterated Rating$2.18Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals1/21/2026Boost Price Target$67.01$100.00Buy$0.0000.00% ROIVIRVir Biotechnology12/30/2025Reiterated Rating$5.98$15.00Buy$0.0000.00% ROIThe S-1 just dropped. 22 days left. (Ad)The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing confirmed. Goldman, Morgan Stanley, and 19 other banks have already carved up the allocation. But buried in those 277 pages is a detail most investors will miss. One small, publicly traded company is so critical to SpaceX's infrastructure that Musk can't scale without it - and the S-1 just confirmed it.Get the 'S-1 Backdoor' ticker name before June 12 closes the windowDRUGBright Minds Biosciences12/30/2025Reiterated Rating$79.38$115.00Buy$0.0000.00% ROIASMBAssembly Biosciences12/22/2025Reiterated Rating$36.19$50.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals12/16/2025Reiterated Rating$1.98$40.00Buy$0.0000.00% ROIMRKRMarker Therapeutics12/8/2025Initiated Coverage$1.42$10.00Buy$0.0000.00% ROIHRMYHarmony Biosciences12/3/2025Reiterated Rating$36.01Buy$0.0000.00% ROIPHVSPharvaris12/3/2025Reiterated Rating$28.08$60.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals12/2/2025Boost Price Target$56.25$85.00Buy$0.0000.00% ROIHRMYHarmony Biosciences11/24/2025Reiterated Rating$34.78$55.00Buy$0.0000.00% ROIONCYOncolytics Biotech11/17/2025Boost Price Target$1.04$10.00Buy$0.0000.00% ROIATAIAtai Beckley11/14/2025Reiterated Rating$4.13Buy$0.0000.00% ROIPHVSPharvaris11/13/2025Reiterated Rating$25.81$60.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics11/12/2025Lower Price Target$4.23$25.00Buy$0.0000.00% ROIGHRSGH Research11/10/2025Lower Price Target$13.54$35.00Buy$0.0000.00% ROIANROAlto Neuroscience10/24/2025Boost Price Target$11.15$50.00Buy$0.0000.00% ROIIMCRImmunocore10/22/2025Reiterated Rating$31.57$100.00Buy$0.0000.00% ROIALTAltimmune10/20/2025Reiterated Rating$3.83$12.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals10/16/2025Reiterated Rating$3.17$40.00Buy$0.0000.00% ROIPHVSPharvaris10/15/2025Initiated Coverage$21.78$60.00Buy$0.0000.00% ROIASMBAssembly Biosciences10/14/2025Reiterated Rating$27.66$50.00Buy$0.0000.00% ROIALTAltimmune10/10/2025Reiterated Rating$4.00$12.00Buy$0.0000.00% ROIBEAMBeam Therapeutics10/10/2025Reiterated Rating$27.87$80.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals10/10/2025Reiterated Rating$456.95$570.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals10/8/2025Reiterated Rating$36.54$80.00Buy$0.0000.00% ROIQUREuniQure10/6/2025Boost Price Target$54.92$110.00Buy$0.0000.00% ROIQUREuniQure10/6/2025Boost Price Target$54.92$110.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals10/1/2025Reiterated Rating$3.30$40.00Buy$0.0000.00% ROIHRMYHarmony Biosciences9/25/2025Lower Price Target$26.76$55.00Buy$0.0000.00% ROIQUREuniQure9/24/2025Reiterated Rating$39.80$70.00Buy$0.0000.00% ROIATAIAtai Beckley9/23/2025Reiterated Rating$5.36$15.00Buy$0.0000.00% ROISLNSilence Therapeutics9/16/2025Reiterated Rating$4.73$75.00Buy$0.0000.00% ROIBEAMBeam Therapeutics9/15/2025Reiterated Rating$20.60$80.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics9/15/2025Reiterated Rating$4.18$30.00Buy$0.0000.00% ROIDRUGBright Minds Biosciences9/15/2025Reiterated Rating$48.75$85.00Buy$0.0000.00% ROIVIRVir Biotechnology9/15/2025Reiterated Rating$4.80$15.00Buy$0.0000.00% ROIALGSAligos Therapeutics9/12/2025Reiterated Rating$10.31$50.00Buy$0.0000.00% ROIALGSAligos Therapeutics8/18/2025Initiated Coverage$7.70$50.00Buy$0.0000.00% ROIANROAlto Neuroscience8/18/2025Reiterated Rating$3.30$10.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupThe Goldman Sachs GroupDeutsche Bank AktiengesellschaftCLSAWall Street ZenCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper Sandler Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
